Refresh

Elder Pharmaceuticals Ltd. - Research Center

532322 ELDERPHARM Group (Z) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Dec ' 14 Dec ' 13 Mar ' 13 Sep ' 12 Mar ' 12

Sales

119.71 291.00 481.31 562.54 501.24

Operating profit

-57.22 67.28 94.61 116.57 102.71

Interest

55.75 76.44 47.15 47.17 41.60

Gross profit

-104.09 -1.71 61.87 81.17 65.65

EPS (Rs)

-58.39 -8.07 18.46 23.79 19.40
Half yearly  results in details
Dec ' 14 Dec ' 13 Mar ' 13 Sep ' 12 Mar ' 12

Other income

8.88 7.45 14.40 11.78 4.53

Stock adjustment

3.60 25.42 -40.54 64.97 -20.68

Raw material

20.32 26.46 41.86 67.73 44.07

Power and fuel

- - - - -

Employee expenses

31.48 51.93 62.40 63.69 60.42

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

121.53 119.91 322.98 249.58 314.72

Provisions made

- - - - -

Depreciation

15.82 14.86 14.21 14.97 12.28

Taxation

- - 9.75 12.25 10.09

Net profit / loss

-119.91 -16.57 37.91 48.86 39.83

Extra ordinary item

- - - -5.09 -3.44

Prior year adjustments

- - - - -

Equity capital

20.54 20.54 20.54 20.54 20.54

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- 151.98 123.24 123.44 124.05

Agg.of non promotoholding (%)

- 74.00 60.01 60.10 60.40

OPM (%)

-47.80 23.12 19.66 20.72 20.49

GPM (%)

-80.95 -.57 12.48 14.13 12.98

NPM (%)

-93.25 -5.55 7.65 8.51 7.88
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com